These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 24402828)
1. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug. Xu Z; Zheng W; Yin Z Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy. Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163 [TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug. Li W; Chen Z; Liu X; Lian M; Peng H; Zhang C Drug Deliv; 2021 Dec; 28(1):1903-1914. PubMed ID: 34519602 [TBL] [Abstract][Full Text] [Related]
4. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles. Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520 [TBL] [Abstract][Full Text] [Related]
5. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin. Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133 [TBL] [Abstract][Full Text] [Related]
6. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980 [TBL] [Abstract][Full Text] [Related]
7. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System. Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660 [TBL] [Abstract][Full Text] [Related]
8. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects. Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086 [TBL] [Abstract][Full Text] [Related]
9. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy. Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519 [TBL] [Abstract][Full Text] [Related]
10. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies. Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate. Henne WA; Kularatne SA; Hakenjos J; Carron JD; Henne KL Bioorg Med Chem Lett; 2013 Nov; 23(21):5810-3. PubMed ID: 24064501 [TBL] [Abstract][Full Text] [Related]
12. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy. He W; Du Y; Zhou W; Wang T; Li M; Li X Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069 [TBL] [Abstract][Full Text] [Related]
13. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting. Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739 [TBL] [Abstract][Full Text] [Related]
14. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release. Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo. Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793 [TBL] [Abstract][Full Text] [Related]
16. Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release. Chen Z; He N; Chen M; Zhao L; Li X Acta Biomater; 2016 Oct; 43():195-207. PubMed ID: 27424081 [TBL] [Abstract][Full Text] [Related]
17. Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery. Hu X; Hu J; Tian J; Ge Z; Zhang G; Luo K; Liu S J Am Chem Soc; 2013 Nov; 135(46):17617-29. PubMed ID: 24160840 [TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation. Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875 [TBL] [Abstract][Full Text] [Related]
19. Stimulus-Responsive Nano-Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery. Chu B; Deng H; Niu T; Qu Y; Qian Z Small Methods; 2024 Aug; 8(8):e2301271. PubMed ID: 38085682 [TBL] [Abstract][Full Text] [Related]
20. Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity. Zhang Z; Tanabe K; Hatta H; Nishimoto S Org Biomol Chem; 2005 May; 3(10):1905-10. PubMed ID: 15889173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]